The Africa CDC leader warned that new U.S. health funding deals could threaten African control over local data and pathogen sharing.
Director-General Jean Kaseya stressed during an online press briefing on Thursday that there are major concerns about data management and the exchange of pathogens.
This issue arose after Zimbabwe pulled out of negotiations for a $367 million, five-year agreement with the United States, citing unfair terms and fears about sensitive information. Similarly, Zambia has raised objections to certain aspects of its own proposed pact.
Countries must swiftly share pathogen data with the U.S. for funding, but critics warn there are no assurances that resulting medicines will reach the hardest-hit countries, raising equity and autonomy concerns.
These deals mark a shift in U.S. global health aid, moving from traditional agency support to direct agreements focused on U.S. interests.
Kaseya initially welcomed the new strategy for promising more direct support and shared investment for African countries. However, he declined a proposal for Africa CDC to serve only as an observer, insisting that every nation should manage its own negotiations.
He further assured that the Africa CDC stands ready to assist any government wishing to review or implement these deals. “I’ve told all member countries they have our full backing.
Whether you want to renegotiate or need Africa CDC present, we will be there,” he stated.
